GB0126723D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0126723D0
GB0126723D0 GB0126723A GB0126723A GB0126723D0 GB 0126723 D0 GB0126723 D0 GB 0126723D0 GB 0126723 A GB0126723 A GB 0126723A GB 0126723 A GB0126723 A GB 0126723A GB 0126723 D0 GB0126723 D0 GB 0126723D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0126723A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB0126723A priority Critical patent/GB0126723D0/en
Publication of GB0126723D0 publication Critical patent/GB0126723D0/en
Priority to ES02078428T priority patent/ES2295283T3/en
Priority to AT02078428T priority patent/ATE376768T1/en
Priority to DE60223205T priority patent/DE60223205T2/en
Priority to US10/223,837 priority patent/US6958433B2/en
Priority to EP02078428A priority patent/EP1285578B1/en
Ceased legal-status Critical Current

Links

GB0126723A 2001-08-21 2001-11-07 Compounds Ceased GB0126723D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0126723A GB0126723D0 (en) 2001-11-07 2001-11-07 Compounds
ES02078428T ES2295283T3 (en) 2001-08-21 2002-08-20 TRANSGENIC ANIMAL MODELS FOR ALZHEIMER'S DISEASE.
AT02078428T ATE376768T1 (en) 2001-08-21 2002-08-20 TRANSGENIC ANIMAL MODEL FOR ALZHEIMER'S DISEASE
DE60223205T DE60223205T2 (en) 2001-08-21 2002-08-20 Transgenic animal model for Alzheimer's disease
US10/223,837 US6958433B2 (en) 2001-08-21 2002-08-20 Transgenic mice overexpressing aspartyl protease 2 (ASP2)
EP02078428A EP1285578B1 (en) 2001-08-21 2002-08-20 Transgenic animal model of Alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0126723A GB0126723D0 (en) 2001-11-07 2001-11-07 Compounds

Publications (1)

Publication Number Publication Date
GB0126723D0 true GB0126723D0 (en) 2002-01-02

Family

ID=9925319

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0126723A Ceased GB0126723D0 (en) 2001-08-21 2001-11-07 Compounds

Country Status (1)

Country Link
GB (1) GB0126723D0 (en)

Similar Documents

Publication Publication Date Title
AU2002349297A8 (en) Statin-like compounds
GB0101996D0 (en) Organtic compounds
GB0112324D0 (en) Compounds
GB0102668D0 (en) Compounds
GB0121488D0 (en) Compounds
GB0108102D0 (en) Compounds
GB0119474D0 (en) Compounds
GB0102673D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0119472D0 (en) Compounds
EP1458669A4 (en) Neuorologically-active compounds
GB0118364D0 (en) Compounds
GB0115178D0 (en) Compounds
GB0120344D0 (en) Compounds
GB0108097D0 (en) Compounds
GB0119473D0 (en) Compounds
GB0105098D0 (en) Compounds
GB0111184D0 (en) Compounds
GB0102670D0 (en) Compounds
GB0105737D0 (en) Compounds
GB0106673D0 (en) Compounds
GB0104399D0 (en) Compounds
GB0104398D0 (en) Compounds
GB0111183D0 (en) Compounds
GB0104397D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)